Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001278386 XXXXXXXX LIVE 42 Common Stock, par value $0.01 per share 12/15/2025 false 0000718937 852312305 STAAR SURGICAL CO 25510 Commercentre Drive Lake Forest CA 92630 Neal C. Bradsher (212) 508-5735 c/o Broadwood Capital, Inc. 156 West 56th Street, 3rd Floor, New York NY 10019 0001278386 N Broadwood Partners, L.P. b WC N DE 0.00 15019491.00 0.00 15019491.00 15019491.00 N 30.2 PN Y Broadwood Capital, Inc. b AF N NY 0.00 15019491.00 0.00 15019491.00 15019491.00 N 30.2 CO IA Y Neal C. Bradsher b AF PF N X1 25900.00 15019491.00 25900.00 15019491.00 15045391.00 N 30.2 IN HC Y Richard T. LeBuhn b PF N X1 21280.00 6.00 21280.00 6.00 21286.00 Y 0.0 IN Box 11 - Does not include 2,532 Shares over which Mr. LeBuhn does not have direct or indirect beneficial ownership. Such shares are held in three separate irrevocable trusts for Mr. LeBuhn's daughters in which Mr. LeBuhn has no voting or dispositive power and disclaims any beneficial ownership interest in such shares. Y Natalie R. Capasso b N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Y Raymond A. Myers b N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Y Jason J. Martin b N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Common Stock, par value $0.01 per share STAAR SURGICAL CO 25510 Commercentre Drive Lake Forest CA 92630 This Amendment No. 42 to the Schedule 13D ("Amendment No. 42"), amends and supplements the statement on Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on October 12, 2004, (the "Original Schedule 13D," as amended, the "Schedule 13D") with respect to shares of common stock, par value $0.01 per share (the "Shares") of STAAR Surgical Company (the "Issuer"). Capitalized terms used but not otherwise defined in this Amendment No. 42 have the meanings set forth in the Schedule 13D. Item 4 is hereby amended and supplemented by the addition of the following: As previously disclosed, the Reporting Persons are engaged in a solicitation to oppose stockholder approval of the Merger Agreement Proposal and the Compensation Proposal at the Special Meeting, which has been postponed until December 19, 2025, and submitted the Appraisal Demands on October 22, 2025 and October 23, 2025. In connection with the Issuer's solicitation and consistent with rights of stockholders of the Issuer under the Merger Agreement and applicable law, Broadwood Partners has determined to exercise its appraisal rights for an additional 1,500,000 Shares it beneficially owns pursuant to Section 262. On December 15, 2025 and December 17, 2025, prior to the taking of the vote on the Proposed Merger and at the request of Broadwood Partners, Cede & Co., the stockholder of record for the 1,500,000 Shares beneficially owned by Broadwood Partners, sent a second written demand, on behalf of Broadwood Partners, for appraisal of 1,500,000 Shares to the Issuer in connection with the Proposed Merger to be voted on at the Special Meeting (the "Second Cede & Co. Appraisal Demand"). The Second Cede & Co. Appraisal Demand does not affect the Appraisal Demands and relates to different Shares from those for which Cede & Co. and Broadwood Partners demanded appraisal of in the Appraisal Demands. While Cede & Co. sent the Second Cede & Co. Appraisal Demand as the stockholder of record for the 1,500,000 Shares, it only did so at the request of Broadwood Partners and as a nominal party. Cede & Co. has no interest in this matter or the 1,500,000 Shares other than to take those steps which are necessary to ensure that Broadwood Partners is not denied its rights as the beneficial owner of the 1,500,000 Shares. As a result, Cede & Co. is not a beneficial owner of the 1,500,000 Shares beneficially owned by Broadwood Partners. The submission of the Second Cede & Co. Appraisal Demand also will have no effect on the outcome of the stockholder vote on the Merger Agreement Proposal or the Compensation Proposal at the Special Meeting. Broadwood Partners reserves all of its rights related to the Second Cede & Co. Appraisal Demand, including, but not limited to, the right under Section 262 to cause Cede & Co. to withdraw the Second Cede & Co. Appraisal Demand at any time prior to, or within 60 days after, the Effective Time (as defined in the Merger Agreement). Item 6 is hereby amended and supplemented by the addition of the following: As a result of the submission of the Second Cede & Co. Appraisal Demand, Broadwood Partners may become entitled to receive payment in cash, constituting the "fair value," in exchange for the 1,500,000 Shares it beneficially owns upon a decree by the Delaware Court of Chancery. The information set forth in Item 4 of this Amendment No. 42 is incorporated herein by reference. Broadwood Partners, L.P. /s/ Neal C. Bradsher Neal C. Bradsher, President of Broadwood Capital, Inc. 12/17/2025 Broadwood Capital, Inc. /s/ Neal C. Bradsher Neal C. Bradsher, President 12/17/2025 Neal C. Bradsher /s/ Neal C. Bradsher Neal C. Bradsher 12/17/2025 Richard T. LeBuhn /s/ Richard T. LeBuhn Richard T. LeBuhn 12/17/2025 Natalie R. Capasso /s/ Natalie R. Capasso Natalie R. Capasso 12/17/2025 Raymond A. Myers /s/ Raymond A. Myers Raymond A. Myers 12/17/2025 Jason J. Martin /s/ Jason J. Martin Jason J. Martin 12/17/2025